| 0 |
CONGENITAL GASTRIC ANOMALY |
1 |
0.0172 |
| 1 |
Q FEVER |
1 |
0.0047 |
| 2 |
SQUAMOUS CELL CARCINOMA OF HEAD AND NECK |
1 |
0.0043 |
| 3 |
LEUKOPLAKIA |
1 |
0.0041 |
| 4 |
CLINODACTYLY |
1 |
0.0036 |
| 5 |
JUVENILE ARTHRITIS |
1 |
0.0030 |
| 6 |
BONE SCAN ABNORMAL |
1 |
0.0024 |
| 7 |
CONGENITAL FOOT MALFORMATION |
1 |
0.0022 |
| 8 |
LIMB REDUCTION DEFECT |
1 |
0.0017 |
| 9 |
INFECTIOUS PERITONITIS |
1 |
0.0015 |
| 10 |
BLOOD MAGNESIUM INCREASED |
1 |
0.0011 |
| 11 |
CEREBRAL PALSY |
1 |
0.0011 |
| 12 |
EYELID RASH |
1 |
0.0010 |
| 13 |
DUODENAL PERFORATION |
1 |
0.0010 |
| 14 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0008 |
| 15 |
MOTION SICKNESS |
1 |
0.0005 |
| 16 |
CYTOMEGALOVIRUS CHORIORETINITIS |
1 |
0.0005 |
| 17 |
BREAST DISORDER |
1 |
0.0005 |
| 18 |
BLOOD TESTOSTERONE INCREASED |
1 |
0.0005 |
| 19 |
LARGE INTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 20 |
IMPLANT SITE INFECTION |
1 |
0.0004 |
| 21 |
DYSMORPHISM |
1 |
0.0004 |
| 22 |
MENOPAUSE |
1 |
0.0004 |
| 23 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 24 |
CLUMSINESS |
1 |
0.0004 |
| 25 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 26 |
PROSTATE CANCER METASTATIC |
1 |
0.0003 |
| 27 |
BODY HEIGHT DECREASED |
3 |
0.0003 |
| 28 |
INTERCEPTED PRODUCT STORAGE ERROR |
1 |
0.0003 |
| 29 |
GINGIVAL DISORDER |
1 |
0.0003 |
| 30 |
OESOPHAGEAL DISORDER |
1 |
0.0003 |
| 31 |
CANDIDIASIS |
1 |
0.0002 |
| 32 |
DEMYELINATION |
1 |
0.0002 |
| 33 |
LEG AMPUTATION |
1 |
0.0002 |
| 34 |
THYROID FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 35 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 36 |
STILLBIRTH |
1 |
0.0002 |
| 37 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 38 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 39 |
STRESS FRACTURE |
1 |
0.0002 |
| 40 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
0.0002 |
| 41 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 42 |
CARDIAC FLUTTER |
1 |
0.0002 |
| 43 |
INCOHERENT |
1 |
0.0002 |
| 44 |
WALKING AID USER |
1 |
0.0002 |
| 45 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 46 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 47 |
DUODENAL ULCER |
1 |
0.0001 |
| 48 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 49 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 50 |
CARDIAC MURMUR |
1 |
0.0001 |
| 51 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 52 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 53 |
OPTIC NEURITIS |
1 |
0.0001 |
| 54 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 55 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 56 |
EAR DISCOMFORT |
1 |
0.0001 |
| 57 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 58 |
WOUND INFECTION |
1 |
0.0001 |
| 59 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 60 |
NOCTURIA |
1 |
0.0001 |
| 61 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 62 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 63 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 64 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 65 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 66 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 67 |
PARALYSIS |
1 |
0.0001 |
| 68 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 69 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 70 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 71 |
FEMUR FRACTURE |
2 |
0.0001 |
| 72 |
BRAIN FOG |
1 |
0.0001 |
| 73 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 74 |
BACK DISORDER |
1 |
0.0001 |
| 75 |
MANIA |
1 |
0.0001 |
| 76 |
LOCAL SWELLING |
1 |
0.0001 |
| 77 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 78 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 79 |
SKIN FISSURES |
1 |
0.0001 |
| 80 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 81 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 82 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 83 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 84 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 85 |
HYPOACUSIS |
2 |
0.0000 |
| 86 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 87 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 88 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 89 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 90 |
DIPLOPIA |
1 |
0.0000 |
| 91 |
OEDEMA |
2 |
0.0000 |
| 92 |
SKIN LESION |
1 |
0.0000 |
| 93 |
FEELING COLD |
1 |
0.0000 |
| 94 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 95 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 96 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 97 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 98 |
FEELING HOT |
2 |
0.0000 |
| 99 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 100 |
PSORIASIS |
4 |
0.0000 |
| 101 |
EYE DISORDER |
1 |
0.0000 |
| 102 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 103 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 104 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 105 |
GASTRIC DISORDER |
1 |
0.0000 |
| 106 |
NIGHTMARE |
1 |
0.0000 |
| 107 |
HEART RATE DECREASED |
1 |
0.0000 |
| 108 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 109 |
BRONCHITIS |
2 |
0.0000 |
| 110 |
ALOPECIA |
5 |
0.0000 |
| 111 |
OSTEOPOROSIS |
1 |
0.0000 |
| 112 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 113 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 114 |
BALANCE DISORDER |
2 |
0.0000 |
| 115 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 116 |
DRY SKIN |
3 |
0.0000 |
| 117 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 118 |
THROAT IRRITATION |
1 |
0.0000 |
| 119 |
DEPRESSION |
5 |
0.0000 |
| 120 |
VISION BLURRED |
3 |
0.0000 |
| 121 |
TINNITUS |
1 |
0.0000 |
| 122 |
HYPOKALAEMIA |
1 |
0.0000 |
| 123 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 124 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 125 |
DRY EYE |
1 |
0.0000 |
| 126 |
LEUKOPENIA |
1 |
0.0000 |
| 127 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 128 |
NERVOUSNESS |
1 |
0.0000 |
| 129 |
SPEECH DISORDER |
1 |
0.0000 |
| 130 |
PANCREATITIS |
1 |
0.0000 |
| 131 |
RASH PRURITIC |
1 |
0.0000 |
| 132 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 133 |
ARTHROPATHY |
1 |
0.0000 |
| 134 |
WEIGHT INCREASED |
4 |
0.0000 |
| 135 |
HYPONATRAEMIA |
1 |
0.0000 |
| 136 |
ASTHMA |
2 |
0.0000 |
| 137 |
LETHARGY |
1 |
0.0000 |
| 138 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 139 |
NASAL CONGESTION |
1 |
0.0000 |
| 140 |
CATARACT |
1 |
0.0000 |
| 141 |
FEELING ABNORMAL |
4 |
0.0000 |
| 142 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 143 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 144 |
DISCOMFORT |
1 |
0.0000 |
| 145 |
SOMNOLENCE |
3 |
0.0000 |
| 146 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 147 |
BURNING SENSATION |
1 |
0.0000 |
| 148 |
CONSTIPATION |
3 |
0.0000 |
| 149 |
UNDERDOSE |
1 |
0.0000 |
| 150 |
AGITATION |
1 |
0.0000 |
| 151 |
DYSGEUSIA |
1 |
0.0000 |
| 152 |
EPISTAXIS |
1 |
0.0000 |
| 153 |
HYPOAESTHESIA |
2 |
0.0000 |
| 154 |
ASTHENIA |
5 |
0.0000 |
| 155 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 156 |
ACNE |
1 |
0.0000 |
| 157 |
DIABETES MELLITUS |
1 |
0.0000 |
| 158 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 159 |
PROSTATE CANCER |
1 |
0.0000 |
| 160 |
THROMBOSIS |
1 |
0.0000 |
| 161 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 162 |
DRY MOUTH |
1 |
0.0000 |
| 163 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 164 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 165 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 166 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 167 |
INSOMNIA |
3 |
0.0000 |
| 168 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 169 |
ADVERSE EVENT |
1 |
0.0000 |
| 170 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 171 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 172 |
BREAST CANCER |
1 |
0.0000 |
| 173 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 174 |
ANAEMIA |
2 |
0.0000 |
| 175 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 176 |
FATIGUE |
8 |
0.0000 |
| 177 |
DIZZINESS |
5 |
0.0000 |
| 178 |
FLUSHING |
1 |
0.0000 |
| 179 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 180 |
FALL |
3 |
0.0000 |
| 181 |
INFLUENZA |
1 |
0.0000 |
| 182 |
DYSPNOEA |
5 |
0.0000 |
| 183 |
SEIZURE |
1 |
0.0000 |
| 184 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 185 |
BACK PAIN |
2 |
0.0000 |
| 186 |
PRURITUS |
3 |
0.0000 |
| 187 |
HYPERHIDROSIS |
1 |
0.0000 |
| 188 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 189 |
NEUTROPENIA |
1 |
0.0000 |
| 190 |
ANXIETY |
2 |
0.0000 |
| 191 |
INFECTION |
1 |
0.0000 |
| 192 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 193 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 194 |
HEADACHE |
4 |
0.0000 |
| 195 |
DIARRHOEA |
4 |
0.0000 |
| 196 |
MYALGIA |
1 |
0.0000 |
| 197 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 198 |
OFF LABEL USE |
5 |
0.0000 |
| 199 |
COVID-19 |
1 |
0.0000 |
| 200 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 201 |
MUSCLE SPASMS |
1 |
0.0000 |
| 202 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 203 |
CHEST PAIN |
1 |
0.0000 |
| 204 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 205 |
ERYTHEMA |
1 |
0.0000 |
| 206 |
HYPERTENSION |
1 |
0.0000 |
| 207 |
DEATH |
4 |
0.0000 |
| 208 |
MALAISE |
2 |
0.0000 |
| 209 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 210 |
DECREASED APPETITE |
1 |
0.0000 |
| 211 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 212 |
NAUSEA |
3 |
0.0000 |
| 213 |
WEIGHT DECREASED |
1 |
0.0000 |
| 214 |
COUGH |
1 |
0.0000 |
| 215 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 216 |
PAIN |
2 |
0.0000 |
| 217 |
PNEUMONIA |
1 |
0.0000 |
| 218 |
PYREXIA |
1 |
0.0000 |
| 219 |
ARTHRALGIA |
1 |
0.0000 |
| 220 |
RASH |
1 |
0.0000 |
| 221 |
VOMITING |
1 |
0.0000 |